 |
The HY1001 project (plant-derived Recombinant human serum albumin injection) of Wuhan Healthgen Biotechnology Corp. (hereinafter referred to as “Healthgen Biotech”), Phase II clinical study completed the enrollment of all subjects in the first cohort. On January 12, 2022, after reviewing and ... Read More
|
| |
April 20, 2022, the "2022 National Intellectual Property Publicity Week Launching Ceremony" and award ceremony of "The 2nd High-value Patent Competition of Hubei Province" hosted by the Hubei Provincial Intellectual Property Office were held at the Hubei Science and Technology Museum. The patent ... Read More
|
| |
January 13, 2022, Wuhan Healthgen Biotechnology Corp. (hereinafter referred to as “Healthgen Biotech”) received the approval of the US Food and Drug Administration (For short "FDA") for the clinical trial of Alpha 1-antitrypsin (AAT) for injection (Project No. HY1003) independently developed by ... Read More
|
| |
Conference Title: Personal Care Technology Summit & Expo 2021 Date: 7/13/2021-7/14/2021 Venue: Pudong Shangri-La, East Shanghai Address: F1 Kerry Parkside, No. 1155, Fangdian Road, Pudong, Shanghai Booth No.: #131 Converging innovative technologies, integrating industry hot topics, and focusing on ... Read More
|
| |
Conference Title: The 12th International Conference on Cell Therapy 2021 Date: 7/9/2021-7/10/2021 Venue: Crown Plaza Shanghai Pujiang Address: No. 3701, Chenhang Road, Shanghai, China Booth No.: #4 After 11 years of precipitation, focusing on next-generation treatments, the 12th International ... Read More
|
| |
February 19th, 2021, the 8th day of the first lunar year, Wuhan Healthgen Biotechnology Corp. (Hereinafter referred to as "Healthgen Biotech") had the starting ceremony of the construction of plant-derived recombinant human serum albumin core technology research project in Optics Valley BioLake. Li ... Read More
|
| |
Healthgen Biotechnology attended the Vaccine World Summit India 2014 at Hyderabad International Convention Centre, India in 4-6 March. Our booth was located in Hall 2. The Vaccine World Summit is the most sought after vaccine conference for India and rest of the developing country manufacturers. ... Read More
|
| |
A research team led by Prof. Daichang Yang, from College of Life Sciences, Wuhan University, and Wuhan Healthgen Biotechnology Co., Ltd. started the research and development of using plant-derived therapeutic proteins to replace the plasma-derived ones since 2006, has achieved a breakthrough in the ... Read More
|
| |
Abstract Soluble epoxide hydrolase (sEH) is an emerging therapeutic target in a number of diseases that have inflammation as a common underlying cause. sEH limits tissue levels of cytochrome P450 (CYP) epoxides derived from omega-6 and omega-3 polyunsaturated fatty acids (PUFA) by converting these ... Read More
|
| |
Your esteemed costomers and related units: Owing to the development of the company, we have removed to Level 1, B6, Biolake on May,2011. Hereon, thanks for your long-term attention and support. We will also continue to provide you products of higher quality and more perfect services. New address:No... Read More
|
| Factory Address:268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020 | |
| Sales office:268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020 | |
| +86-27-59301891-8015 | |
| caojing@oryzogen.com | |
